Xudong Yuan1, Bruhal A Shah, Naimesh K Kotadia, Jian Li, Hua Gu, Zhiqian Wu. 1. Division of Pharmaceutical Sciences, Arnold & Marie Schwartz College of Pharmacy, Long Island University, 75 DeKalb Avenue, Brooklyn, New York 11201-5497, USA. xudong.yuan@liu.edu
Abstract
PURPOSE: In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. METHODS: CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. RESULTS: It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. CONCLUSION: This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications.
PURPOSE: In order to improve siRNA delivery for possible clinical applications, we developed biodegradable chitosan-modified poly(D,L-lactide-co-glycolide) (CHT-PLGA) nanoparticles with positive surface charge, high siRNA loading, high transfection efficiency and low toxicity. METHODS: CHT-PLGA nanoparticles were prepared, and siRNA was loaded by emulsion evaporation method with poly(vinyl alcohol) (PVA) as emulsifier. siRNA loading efficiency, particle size, and Zeta potential of nanoparticles were measured. Gel retardation and protection assays were conducted to determine the loading and binding of siRNA in the formulation. Cell transfection was performed to study in vitro siRNA silencing efficiency. XTT assay was used to evaluate the cytotoxicity. RESULTS: It was found that the nanoparticle diameter and positive Zeta potential increase as the chitosan coating concentration increases. CHT-PLGA nanoparticles showed excellent siRNA binding ability and effective protection of oligos from RNase degradation. siRNA-loaded nanoparticles were successfully delivered into the HEK 293 T cell line, and the silencing of green fluorescence protein (GFP) expression was observed using fluorescent microscopy and flow cytometry. In addition, the cytotoxicity assay revealed that CHT-PLGA nanoparticles had relatively low cytotoxicity. CONCLUSION: This study suggests that biodegradable cationic CHT-PLGA nanoparticles possess great potential for efficient and safer siRNA delivery in future clinical applications.
Authors: S Taetz; N Nafee; J Beisner; K Piotrowska; C Baldes; T E Mürdter; H Huwer; M Schneider; U F Schaefer; U Klotz; C-M Lehr Journal: Eur J Pharm Biopharm Date: 2008-07-27 Impact factor: 5.571
Authors: Raquel T Lima; Luís M Martins; José E Guimarães; Clara Sambade; M Helena Vasconcelos Journal: Cancer Gene Ther Date: 2004-05 Impact factor: 5.987
Authors: Paschalia M Mountziaris; David C Sing; Sue Anne Chew; Stephanie N Tzouanas; E Dennis Lehman; F Kurtis Kasper; Antonios G Mikos Journal: Pharm Res Date: 2010-12-24 Impact factor: 4.200
Authors: Elina Esmaeilzadeh Gharehdaghi; Amir Amani; Mohammad Reza Khoshayand; Mehdi Banan; Elika Esmaeilzadeh Gharehdaghi; Mohammad Ali Amini; Mohammad Ali Faramarzi Journal: Nucleic Acid Ther Date: 2014-12 Impact factor: 5.486